Interagency Communication On Trial Designs Urged At FDA/NIH Stakeholder Meeting

New FDA/NIH council co-chaired by FDA Commissioner Hamburg and NIH Director Collins includes six additional members from each agency.

More from Archive

More from Pink Sheet